Feifeng Li; Junmou Xie; Wenbo Gao; Fenfang Liao; Haojian Liang; Rongsong Du; Zhongping Li; Yongmei Nie; Yongshui Fu; Ru Xu; Shijie Li; Hao Wang; Huaqin Liang; Feifeng Li; Junmou Xie; Wenbo Gao; Fenfang Liao; Haojian Liang; Rongsong Du; Zhongping Li; Yongmei Nie; Yongshui Fu; Ru Xu; Shijie Li; Hao Wang; Huaqin Liang

doi:10.46234/ccdcw2025.133

[1]

Zaller N, Nelson KE, Ness P, Wen GX, Kewir T, Bai XH, et al. Demographic characteristics and risks for transfusion-transmissible infection among blood donors in Xinjiang autonomous region, People’s Republic of China. Transfusion 2006;46(2):265 − 71. https://doi.org/10.1111/j.1537-2995.2006.00711.x.

[2]

Ji ZH, Li CY, Lv YG, Cao W, Chen YZ, Chen XP, et al. The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi’an, China between 1999 and 2009. Int J Infect Dis 2013;17(4):e259 − 62. https://doi.org/10.1016/j.ijid.2012.10.006.

[3]

Song Y, Bian Y, Petzold M, Ung COL. Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010. PLoS One 2014;9(4):e94528. https://doi.org/10.1371/journal.pone.0094528.

[4]

Li L, Li KY, Yan K, Ou GJ, Li WH, Wang J, et al. The history and challenges of blood donor screening in China. Transfus Med Rev 2017;31(2):89 − 93. https://doi.org/10.1016/j.tmrv.2016.11.001.

[5]

Wu DX, Feng FJ, Wang XJ, Wang DR, Hu YQ, Yu Y, et al. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review. BMC Infect Dis 2022;22(1):279. https://doi.org/10.1186/s12879-022-07279-5.

[6]

Yang SG, Jiao DM, Liu CJ, Lv M, Li S, Chen ZY, et al. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses, and Treponema pallidum infections among blood donors at Shiyan, Central China. BMC Infect Dis 2016;16(1):531. https://doi.org/10.1186/s12879-016-1845-z.

[7]

Li CQ, Xiao XP, Yin HM, He M, Li JP, Dai YD, et al. Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four Chinese regional blood centers between 2000 and 2010. J Transl Med 2012;10(1):176. https://doi.org/10.1186/1479-5876-10-176.

[8]

Bai SW, Dang W, Hong WY, Liao WY, Smith RD. The prevalence of hepatitis B in Chinese general population from 2018 to 2022: a systematic review and meta-analysis. BMC Infect Dis 2024;24(1):211. https://doi.org/10.1186/s12879-024-09103-8.

[9]

Han MJ. Analysis of HIV/AIDS Epidemic Situation and Prospects for Prevention and Control in China. Chinese Journal of AIDS & STD 2023;29(03):247-250. https://doi:10.13419/j.cnki.aids.2023.03.01

[10]

Liu L, Wang L, Zhang H, Ou WD, Li D, Feng Y, et al. Changing epidemiology of hepatitis B virus and hepatitis C virus coinfection in a human immunodeficiency virus-positive population in China: results from the third and fourth nationwide molecular epidemiologic surveys. Clin Infect Dis 2021;73(4):642 − 9. https://doi.org/10.1093/cid/ciab058.

[11]

Chang L, Zhao JP, Guo F, Ji HM, Zhang L, Jiang XY, et al. Demographic characteristics of transfusion-transmitted infections among blood donors in China. BMC Infect Dis 2019;19(1):514. https://doi.org/10.1186/s12879-019-4044-x.

[12]

Wu XB, Guan Y, Ye JB, Fu HL, Zhang CL, Lan LN, et al. Association between syphilis seroprevalence and age among blood donors in Southern China: an observational study from 2014 to 2017. BMJ Open 2019;9(11):e024393. https://doi.org/10.1136/bmjopen-2018-024393.